The Diagnostic Accuracy of Non-Echo-Planar Diffusion-Weighted Imaging in the Detection of Residual and/or Recurrent Cholesteatoma of the Temporal Bone

References

1. 1.↵
   1. Semaan MT,
   2. Megerian CA

   . The pathophysiology of cholesteatoma. Otolaryngol Clin North Am 2006; 39: 1143– 59

   CrossRefPubMed
2. 2.↵
   1. Persaud R,
   2. Hajioff D,
   3. Trinidade A,
   4. et al

   . Evidence-based review of aetiopathogenic theories of congenital and acquired cholesteatoma. J Laryngol Otol 2007; 121: 1013– 19. Epub 2007 Aug 15

   PubMed
3. 3.↵
   1. Mustafa A,
   2. Heta A,
   3. Kastrati B,
   4. et al

   . Complications of chronic otitis media with cholesteatoma during a 10-year period in Kosovo. Eur Arch Otorhinolaryngol 2008; 265: 1477– 82

   CrossRefPubMed
4. 4.↵
   1. Smith A,
   2. Danner CJ

   . Complications of chronic otitis media and cholesteatoma. Otolaryngol Clin North Am 2006; 39: 1237– 55

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Ajalloueyan M

   . Experience with surgical management of cholesteatomas. Arch Otolaryngol Head Neck Surg 2006; 132: 931– 33

   CrossRefPubMed
6. 6.↵
   1. Chadha NK,
   2. Jardine A,
   3. Owens D,
   4. et al

   . A multivariate analysis of the factors predicting hearing outcome after surgery for cholesteatoma in children. J Laryngol Otol 2006; 120: 908– 13

   PubMed
7. 7.↵
   1. Stangerup SE,
   2. Drozdziewics D,
   3. Tos M,
   4. et al

   . Surgery for acquired cholesteatoma in children: long-term results and recurrence of cholesteatoma. J Laryngol Otol 1998; 112: 742– 49

   PubMed
8. 8.↵
   1. Sie KC

   . Cholesteatoma in children. Pediatr Clin North Am 1996; 43: 1245– 52

   CrossRefPubMed
9. 9.↵
   1. Roger G,
   2. Denoyelle F,
   3. Chauvin P,
   4. et al

   . Predictive risk factors of residual cholesteatoma in children: a study of 256 cases. Am J Otol 1997; 18: 550– 58

   PubMedWeb of Science
10. 10.↵
    1. Lemmerling MM,
    2. De Foer B,
    3. VandeVyver V,
    4. et al

    . Imaging of the opacified middle ear. Eur J Radiol 2008; 66: 363– 71. Epub 2008 Mar 12

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Williams MT,
    2. Ayache D,
    3. Alberti C,
    4. et al

    . Detection of postoperative residual cholesteatoma with delayed contrast-enhanced MR imaging: initial findings. Eur Radiol 2003; 13: 169– 74

    PubMedWeb of Science
12. 12.↵
    1. Pisaneschi MJ,
    2. Langer B

    . Congenital cholesteatoma and cholesterol granuloma of the temporal bone: role of magnetic resonance imaging. Top Magn Reson Imaging 2000; 11: 87– 97

    CrossRefPubMed
13. 13.↵
    1. Martin N,
    2. Sterkers O,
    3. Nahum H

    . Chronic inflammatory disease of the middle ear cavities: Gd-DTPA-enhanced MR imaging. Radiology 1999; 212: 333– 39

    CrossRefPubMedWeb of Science
14. 14.↵
    1. De Foer B,
    2. Vercruysse JP,
    3. Bernaerts A,
    4. et al

    . Detection of postoperative residual cholesteatoma with non-echo-planar diffusion-weighted magnetic resonance imaging. Otol Neurotol 2008; 29: 513– 17

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Dhepnorrarat RC,
    2. Wood B,
    3. Rajan GP

    . Postoperative non-echo-planar diffusion-weighted magnetic resonance imaging changes after cholesteatoma surgery: implications for cholesteatoma screening. Otol Neurotol 2008; 30: 54– 58

    CrossRef
16. 16.↵
    1. De Foer B,
    2. Vercruysse JP,
    3. Bernaerts A,
    4. et al

    . The value of single-shot turbo spin-echo diffusion-weighted MR imaging in the detection of middle ear cholesteatoma. Neuroradiology 2007; 49: 841– 48

    CrossRefPubMed
17. 17.↵
    1. Dubrulle F,
    2. Souillard R,
    3. Chechin D,
    4. et al

    . Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma. Radiology 2006; 238: 604– 10

    CrossRefPubMed
18. 18.↵
    1. Vercruysse JP,
    2. De Foer B,
    3. Pouillon M,
    4. et al

    . The value of diffusion-weighted MR imaging in the diagnosis of primary acquired and residual cholesteatoma: a surgical verified study of 100 patients. Eur Radiol 2006; 16: 1461– 67

    CrossRefPubMedWeb of Science
19. 19.↵
    1. De Foer B,
    2. Vercruysse JP,
    3. Spaepen M,
    4. et al

    . Diffusion-weighted magnetic resonance imaging of the temporal bone. Neuroradiology 2010; 52: 785– 807

    CrossRefPubMed
20. 20.↵
    1. Rajan GP,
    2. Ambett R,
    3. Wun L,
    4. et al

    . Preliminary outcomes of cholesteatoma screening in children using non-echo-planar diffusion-weighted magnetic resonance imaging. Int J Pediatr Otorhinolaryngol 2010; 74: 297– 301

    CrossRefPubMed
21. 21.↵
    1. Schwartz KM,
    2. Lane JI,
    3. Bolster BD,
    4. et al

    . The utility of diffusion-weighted imaging for cholesteatoma evaluation. AJNR Am J Neuroradiol 2011; 32: 430– 36

    Abstract/FREE Full Text
22. 22.↵
    1. Annet L,
    2. Duprez T,
    3. Grandin C,
    4. et al

    . Apparent diffusion coefficient measurements within intracranial epidermoid cysts in six patients. Neuroradiology 2002; 44: 326– 28

    CrossRefPubMed
23. 23.↵
    1. Thiriat S,
    2. Riehm S,
    3. Kremer S,
    4. et al

    . Apparent diffusion coefficient values of middle ear cholesteatoma differ from abscess and cholesteatoma admixed infection. AJNR Am J Neuroradiol 2009; 30: 1123– 26

    Abstract/FREE Full Text
24. 24.↵
    1. Kösling S,
    2. Bootz F

    . CT and MR imaging after middle ear surgery. Eur J Radiol 2001; 40: 113– 18

    CrossRefPubMed
25. 25.↵
    1. De Foer B,
    2. Vercruysse JP,
    3. Bernaerts A,
    4. et al

    . Middle ear cholesteatoma: non-echo-planar diffusion-weighted MR imaging versus delayed gadolinium-enhanced T1-weighted MR imaging—value in detection. Radiology 2010; 255: 866– 72

    CrossRefPubMed